No Data
Mural Oncology Welcomes George Golumbeski as Director
Express News | Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.d., to Its Board of Directors
Mural Oncology Initiated at Buy by Rodman & Renshaw
Express News | Rodman & Renshaw Initiates Coverage On Mural Oncology With Buy Rating, Announces Price Target of $15
Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
Express News | Mural Oncology Shares Data From ARTISTRY-3 Trial Designed To Evaluate Effects Of Less Frequent Intravenous Dosing Of Nemvaleukin Alfa In Advance Of ASCO Annual Meeting